Cancer Research Annual Meeting 2010  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 3257-3260, June 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, G.-H.
Right arrow Articles by Kitagawa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, G.-H.
Right arrow Articles by Kitagawa, T.

Strain Specific Sensitivity to Diethylnitrosamine-induced Carcinogenesis Is Maintained in Hepatocytes of C3H/HeN{leftrightarrow}C57BL/6N Chimeric Mice1

Gang-Hong Lee2, Kimie Nomura, Hiroaki Kanda, Moriaki Kusakabe, Atsushi Yoshiki, Teruyo Sakakura and Tomoyuki Kitagawa

Department of Pathology, Cancer Institute, Toshima-ku, Tokyo 170 [G-H. L., K. N., H. K., T. K.], and Laboratory of Cell Biology, Tsukuba Life Science Center, The Institute of Physical and Chemical Research (RIKEN), Ibaraki 305 [M. K., A. Y., T. S.], Japan

The C3H/HeN (C3H) and C57BL/6N (C57) mouse strains are known, respectively, for their high and low susceptibility to both spontaneous and chemically induced hepatocarcinogenesis. The present study was aimed at elucidating whether this difference is dependent on intrinsic features of the target hepatocytes or the in vivo milieu and associated growth promoting factors to which the cells are exposed. C3H{leftrightarrow}C57 chimeric mice were produced and given injections of diethylnitrosamine (20 µg/g body weight) at the age of 15 days. The animals were sacrificed 6 or 9 months thereafter, and the numbers and sizes of altered cell lesions were scored. The clonal growth of both cell types was immunohistochemically confirmed using anti C3H-specific antigen antibodies. Quantitative assessment revealed C3H lesions in the chimera livers to be far larger (5:1) than those of C57 derivation and associated with more frequent malignant progression as was evident histologically. Furthermore, foamy change and hyalin body formation, which have been described as characteristics of C3H and C57BL hepatic tumors, respectively, were also featured as differentiative characteristics in lesions of both cell types in chimera mice. Thus, the results clearly demonstrated that the principal mechanism(s) underlying strain difference in diethylnitrosamine-initiated hepatocarcinogenesis exists in the target cells and is not milieu-dependent.

1 Supported by Grants-in-Aid for Cancer Research from the Ministry of Education, Science, and Culture and the Ministry of Health and Welfare of Japan, and by Grants from the Princess Takamatsu Cancer Research Fund.

2 To whom requests for reprints should be addressed.

Received 12/10/90. Accepted 4/ 1/91.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
S. E.-M. Peychal, A. Bilger, H. C. Pitot, and N. R. Drinkwater
Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17
Carcinogenesis, May 1, 2009; 30(5): 879 - 885.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
A. Bilger, L. M. Bennett, R. A. Carabeo, T. A. Chiaverotti, C. Dvorak, K. M. Liss, S. A. Schadewald, H. C. Pitot, and N. R. Drinkwater
A Potent Modifier of Liver Cancer Risk on Distal Mouse Chromosome 1: Linkage Analysis and Characterization of Congenic Lines
Genetics, June 1, 2004; 167(2): 859 - 866.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. A. Chiaverotti and N. R. Drinkwater
C57BR/cdJ Hepatocarcinogen Susceptibility Genes Act Cell-Autonomously in C57BR/cdJ{leftrightarrow}C57BL/6J Chimeras
Cancer Res., August 15, 2003; 63(16): 4914 - 4919.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. A. Dragani
10 Years of Mouse Cancer Modifier Loci: Human Relevance
Cancer Res., June 15, 2003; 63(12): 3011 - 3018.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
T. L. Goldsworthy and R. Fransson-Steen
Quantitation of the Cancer Process in C57BL/6J, B6C3F1 and C3H/HeJ Mice
Toxicol Pathol, January 1, 2002; 30(1): 97 - 105.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
J. M. Bugni, T. M. Poole, and N. R. Drinkwater
The little mutation suppresses DEN-induced hepatocarcinogenesis in mice and abrogates genetic and hormonal modulation of susceptibility
Carcinogenesis, November 1, 2001; 22(11): 1853 - 1862.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
G.-H. Lee
Review Article: Paradoxical Effects of Phenobarbital on Mouse Hepatocarcinogenesis
Toxicol Pathol, March 1, 2000; 28(2): 215 - 225.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.